These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
312 related articles for article (PubMed ID: 19031311)
1. Ciprofloxacin liposomes as vesicular reservoirs for ocular delivery: formulation, optimization, and in vitro characterization. Mehanna MM; Elmaradny HA; Samaha MW Drug Dev Ind Pharm; 2009 May; 35(5):583-93. PubMed ID: 19031311 [TBL] [Abstract][Full Text] [Related]
3. Ophthalmic controlled release in situ gelling systems for ciprofloxacin based on polymeric carriers. Al-Kassas RS; El-Khatib MM Drug Deliv; 2009 Apr; 16(3):145-52. PubMed ID: 19514974 [TBL] [Abstract][Full Text] [Related]
4. Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment. Mehanna MM; Elmaradny HA; Samaha MW Drug Dev Ind Pharm; 2010 Jan; 36(1):108-18. PubMed ID: 19656004 [TBL] [Abstract][Full Text] [Related]
5. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation. Motwani SK; Chopra S; Talegaonkar S; Kohli K; Ahmad FJ; Khar RK Eur J Pharm Biopharm; 2008 Mar; 68(3):513-25. PubMed ID: 17983737 [TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of nanosized niosomal dispersion for oral delivery of Ganciclovir. Akhter S; Kushwaha S; Warsi MH; Anwar M; Ahmad MZ; Ahmad I; Talegaonkar S; Khan ZI; Khar RK; Ahmad FJ Drug Dev Ind Pharm; 2012 Jan; 38(1):84-92. PubMed ID: 21726136 [TBL] [Abstract][Full Text] [Related]
7. Design and statistical optimization of glipizide loaded lipospheres using response surface methodology. Shivakumar HN; Patel PB; Desai BG; Ashok P; Arulmozhi S Acta Pharm; 2007 Sep; 57(3):269-85. PubMed ID: 17878108 [TBL] [Abstract][Full Text] [Related]
8. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Mokhtar M; Sammour OA; Hammad MA; Megrab NA Int J Pharm; 2008 Sep; 361(1-2):104-11. PubMed ID: 18577437 [TBL] [Abstract][Full Text] [Related]
9. Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits. Fouda NH; Abdelrehim RT; Hegazy DA; Habib BA Drug Deliv; 2018 Nov; 25(1):1340-1349. PubMed ID: 29869516 [TBL] [Abstract][Full Text] [Related]
10. Preparation and in vitro evaluation of liposomal chloroquine diphosphate loaded by a transmembrane pH-gradient method. Qiu L; Jing N; Jin Y Int J Pharm; 2008 Sep; 361(1-2):56-63. PubMed ID: 18573626 [TBL] [Abstract][Full Text] [Related]
11. Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization. Abdelkader H; Ismail S; Kamal A; Alany RG Pharmazie; 2010 Nov; 65(11):811-7. PubMed ID: 21155387 [TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of niosomes containing ribavirin for liver targeting. Hashim F; El-Ridy M; Nasr M; Abdallah Y Drug Deliv; 2010 Jul; 17(5):282-7. PubMed ID: 20350052 [TBL] [Abstract][Full Text] [Related]
13. Design and in vitro characterization of small unilamellar niosomes as ophthalmic carrier of dorzolamide hydrochloride. Hasan AA Pharm Dev Technol; 2014 Sep; 19(6):748-54. PubMed ID: 23964893 [TBL] [Abstract][Full Text] [Related]
14. Influence of membrane components on the stability and drug release properties of reverse phase evaporation vesicles (REVs): light sensitive all-trans retinal, negatively charged phospholipid dicetylphosphate and cholesterol. Gürsel M; Hasirci V J Microencapsul; 1995; 12(6):661-9. PubMed ID: 8558388 [TBL] [Abstract][Full Text] [Related]
15. Novel poly-DL-lactide-polycaprolactone copolymer based flexible drug delivery system for sustained release of ciprofloxacin. Waknis V; Jonnalagadda S Drug Deliv; 2011 May; 18(4):236-45. PubMed ID: 21189060 [TBL] [Abstract][Full Text] [Related]
16. Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. Manconi M; Sinico C; Valenti D; Lai F; Fadda AM Int J Pharm; 2006 Mar; 311(1-2):11-9. PubMed ID: 16439071 [TBL] [Abstract][Full Text] [Related]
17. Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery. Sweeney LG; Wang Z; Loebenberg R; Wong JP; Lange CF; Finlay WH Int J Pharm; 2005 Nov; 305(1-2):180-5. PubMed ID: 16242277 [TBL] [Abstract][Full Text] [Related]
18. Gels and liposomes in optimized ocular drug delivery: studies on ciprofloxacin formulations. Budai L; Hajdú M; Budai M; Gróf P; Béni S; Noszál B; Klebovich I; Antal I Int J Pharm; 2007 Oct; 343(1-2):34-40. PubMed ID: 17537601 [TBL] [Abstract][Full Text] [Related]
19. Formulation and in vitro evaluation of ciprofloxacin containing niosomes for pulmonary delivery. Moazeni E; Gilani K; Sotoudegan F; Pardakhty A; Najafabadi AR; Ghalandari R; Fazeli MR; Jamalifar H J Microencapsul; 2010; 27(7):618-27. PubMed ID: 20681747 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models. Tabbakhian M; Tavakoli N; Jaafari MR; Daneshamouz S Int J Pharm; 2006 Oct; 323(1-2):1-10. PubMed ID: 16837150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]